Consumer Discretionary • Shoe Manufacturing
$38.42 ▲ +1.27
(+3.42%)
MKT CAP: $57.07B • VOL: 21.70M
52W L $32 52W H $69
NKE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-05-31 | FY 2024
FILED 2025-05-31 | FY 2023
FILED 2024-05-31 |
|---|---|---|---|
| Revenue (Total Sales) | $46.40B | $46.31B | $51.36B |
| YoY Revenue Growth % | +0.2% | -9.8% | — |
| Gross Profit | $19.91B | $19.79B | $22.60B |
| Gross Margin % | 42.9% | 42.7% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.67B | $3.80B | $6.73B |
| Operating Margin % | 7.9% | 8.2% | 13.1% |
| Net Income (GAAP) | $3.11B | $3.22B | $5.70B |
| EBITDA (Normalized) | $4.21B | $4.14B | $8.58B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.87B | $3.70B | $7.43B |
| Capital Expenditures (CapEx) | $684.0M | $430.0M | $2.31B |
| Free Cash Flow (FCF) | $2.18B | $3.27B | $5.12B |
| FCF Margin % | 4.7% | 7.1% | 10.0% |
| Return on Invested Capital (ROIC %) | 20.5% | 21.4% | 14.3% |
| Cash & Short-Term Equivalents | $6.97B | $7.98B | $6.78B |
| Total Debt (Short + Long Term) | $7.02B | $7.97B | $14.42B |
| Total Stockholders' Equity | $14.09B | $14.04B | $29.58B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NKE.